Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Telomir Pharmaceuticals, Inc. | Director | Common Stock | 488K | $3.02M | $6.20 | Feb 8, 2024 | Direct |
Guardant Health, Inc. | Chief Medical Officer | Common Stock | 32.6K | $1.38M | $42.47 | Apr 1, 2025 | Direct |
Guardant Health, Inc. | Chief Medical Officer | Performance-Based Restricted Stock Units | 11.4K | $534K | $46.98 | Mar 1, 2025 | Direct |
Guardant Health, Inc. | Chief Medical Officer | Restricted Stock Units | 10K | $425K | $42.47 | Apr 1, 2025 | Direct |
MyMD Pharmaceuticals, Inc. | Director | Employee Stock Option (Right to Buy) | 475K | Jun 7, 2023 | Direct | ||
Guardant Health, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 24.4K | Mar 12, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GH | Guardant Health, Inc. | Apr 1, 2025 | 5 | -$55K | 4 | Apr 2, 2025 | Chief Medical Officer |
GH | Guardant Health, Inc. | Mar 15, 2025 | 3 | -$21.4K | 4 | Mar 18, 2025 | Chief Medical Officer |
GH | Guardant Health, Inc. | Mar 12, 2025 | 2 | $0 | 4 | Mar 13, 2025 | Chief Medical Officer |
GH | Guardant Health, Inc. | Mar 1, 2025 | 3 | -$86.3K | 4 | Mar 4, 2025 | Chief Medical Officer |
GH | Guardant Health, Inc. | Jan 1, 2025 | 5 | -$42.4K | 4 | Jan 3, 2025 | Chief Medical Officer |
GH | Guardant Health, Inc. | Dec 15, 2024 | 3 | -$24.7K | 4 | Dec 16, 2024 | Chief Medical Officer |
GH | Guardant Health, Inc. | Nov 8, 2024 | 2 | $0 | 4 | Nov 12, 2024 | Chief Medical Officer |
GH | Guardant Health, Inc. | Oct 1, 2024 | 5 | -$92.9K | 4 | Oct 2, 2024 | Chief Medical Officer |
GH | Guardant Health, Inc. | Sep 15, 2024 | 3 | -$19K | 4 | Sep 16, 2024 | Chief Medical Officer |
GH | Guardant Health, Inc. | Jul 1, 2024 | 3 | -$17.3K | 4 | Jul 2, 2024 | Chief Medical Officer |
GH | Guardant Health, Inc. | Jun 15, 2024 | 3 | -$59.5K | 4 | Jun 17, 2024 | Chief Medical Officer |
GH | Guardant Health, Inc. | May 15, 2024 | 3 | -$34.2K | 4 | May 16, 2024 | Chief Medical Officer |
GH | Guardant Health, Inc. | Apr 1, 2024 | 3 | -$12.6K | 4 | Apr 2, 2024 | Chief Medical Officer |
TELO | Telomir Pharmaceuticals, Inc. | Feb 8, 2024 | 0 | $0 | 3 | Feb 8, 2024 | Director |
GH | Guardant Health, Inc. | Jan 1, 2024 | 3 | -$19K | 4 | Jan 3, 2024 | Chief Medical Officer |
GH | Guardant Health, Inc. | Dec 13, 2023 | 2 | $0 | 4 | Dec 15, 2023 | Chief Medical Officer |
GH | Guardant Health, Inc. | Oct 1, 2023 | 3 | -$70.3K | 4 | Oct 2, 2023 | Chief Medical Officer |
GH | Guardant Health, Inc. | Jun 9, 2023 | 2 | $0 | 4 | Jun 13, 2023 | Chief Medical Officer |
MYMD | MyMD Pharmaceuticals, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
GH | Guardant Health, Inc. | May 15, 2023 | 3 | -$35.9K | 4 | May 16, 2023 | Chief Medical Officer |
GH | Guardant Health, Inc. | Nov 7, 2022 | 2 | $0 | 4 | Nov 9, 2022 | CHIEF MEDICAL OFFICER |
GH | Guardant Health, Inc. | May 15, 2022 | 3 | -$46.2K | 4 | Sep 8, 2022 | CHIEF MEDICAL OFFICER |
MYMD | MyMD Pharmaceuticals, Inc. | Oct 14, 2021 | 1 | $0 | 4 | Oct 15, 2021 | Director |
GH | Guardant Health, Inc. | Aug 3, 2021 | 2 | $0 | 4 | Aug 5, 2021 | CHIEF MEDICAL OFFICER |
GH | Guardant Health, Inc. | May 4, 2021 | 0 | $0 | 3 | May 13, 2021 | CHIEF MEDICAL OFFICER |